Cibc Private Wealth Group, LLC Inovio Pharmaceuticals, Inc. Transaction History

Cibc Private Wealth Group, LLC

  • $53.9 Billion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Nov 21, 2023
BUY
$0.39 - $0.94 $46,452 - $111,963
119,110 New
119,110 $53,000
Q2 2023

Aug 10, 2023
BUY
$0.39 - $0.94 $46,452 - $111,963
119,110 New
119,110 $53,000
Q1 2023

Nov 21, 2023
BUY
$0.79 - $1.91 $26,156 - $63,240
33,110 New
33,110 $27,000
Q3 2022

Nov 14, 2022
BUY
$1.66 - $2.79 $54,962 - $92,376
33,110 New
33,110 $57,000
Q1 2019

May 10, 2019
SELL
$3.34 - $5.1 $215,430 - $328,950
-64,500 Closed
0 $0
Q4 2018

Feb 05, 2019
BUY
$3.89 - $6.11 $250,905 - $394,095
64,500 New
64,500 $258,000

Others Institutions Holding INO

# of Institutions
10
Shares Held
281K
Call Options Held
0
Put Options Held
0
View Full List

About INOVIO PHARMACEUTICALS, INC.

INO Quotes by TradingView
  • Ticker INO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 249,400,000
  • Market Cap $459M
  • Description
  • Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...
More about INO
Track This Portfolio

Track Cibc Private Wealth Group, LLC Portfolio

Follow Cibc Private Wealth Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Private Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Private Wealth Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email